James P. Mackin - 07 Feb 2022 Form 4 Insider Report for ARTIVION, INC. (AORT)

Role
President & CEO
Signature
/s/ James P Mackin
Issuer symbol
AORT
Transactions as of
07 Feb 2022
Net transactions value
-$184,052
Form type
4
Filing time
08 Feb 2022, 15:38:34 UTC
Next filing
10 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Options Exercise $117,018 +10,638 +3.5% $11.00 314,816 07 Feb 2022 Direct F1
transaction AORT Common Stock Sale $184,052 -10,638 -3.4% $17.30 304,178 07 Feb 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT StockOption(Right To Buy) Options Exercise $117,018 -10,638 -25% $11.00 31,915 07 Feb 2022 Common Stock 10,638 $11.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Sept 3, 2021
F2 Reflects weighted average price. Range of prices were between $16.90 to $17.51. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/19/2016